eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools   Community
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Ask question       Write review       Answered/ Unanswered       Reviews       WellConnected

From FDA reports: drug interactions between Claforan, Netilmicin Sulfate, Doxicillin Sodium, Clavulanate Potassium for a Male patient aged 84

This is a personalized study for a 84 year old male patient. The study is created by eHealthMe based on reports of 10 people who take the same drugs and have drug interactionsfrom FDA.

On Oct, 31, 2014: 10 people who reported to have interactions when taking Claforan, Netilmicin Sulfate, Doxicillin Sodium, Clavulanate Potassium are studied

Trend of Claforan, Netilmicin Sulfate, Doxicillin Sodium, Clavulanate Potassium's drug interactions, side effects, and effectiveness reports (1759957)

Information of the patient in this study:

Age: 84

Gender: male

Drugs taking:
- Claforan
- Netilmicin Sulfate
- Doxicillin Sodium
- Clavulanate Potassium

Drug interactions have: Renal Failure Nos, Respiratory Failure (exc Neonatal), Sepsis Nos, Staphylococcal Infection Nos, Toxicoderma

eHealthMe real world results:

Comparison with this patient's adverse outcomes among males aged 84 (±5):

InteractionNumber of reports
Renal Failure Nos2 (100.00%)
Respiratory Failure (exc Neonatal) (inadequate gas exchange by the respiratory system(excluding neonatal))2 (100.00%)
Sepsis Nos2 (100.00%)
Staphylococcal Infection Nos2 (100.00%)
Toxicoderma (a disease of the skin caused by a toxic agent)2 (100.00%)

Most common interactions experienced by males aged 84 (±5) in the use of Claforan, Netilmicin Sulfate, Doxicillin Sodium, Clavulanate Potassium:

InteractionNumber of reports
Renal Failure Nos2
Staphylococcal Infection Nos2
Sepsis Nos2
Blood Creatinine Increased2
Respiratory Failure (exc Neonatal) (inadequate gas exchange by the respiratory system(excluding neonatal))2
Confusion2
Upper Respiratory Tract Infection Nos2
Depression Nec (depression not elsewhere classified)2
Dermatitis Bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)2
Dermatitis Nos2

Most common interactions experienced by males aged 84 (±5) in long term use of Claforan, Netilmicin Sulfate, Doxicillin Sodium, Clavulanate Potassium:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Renal Failure Nos4 (40.00%)
Respiratory Failure (exc Neonatal) (inadequate gas exchange by the respiratory system(excluding neonatal))2 (20.00%)
Sepsis Nos4 (40.00%)
Staphylococcal Infection Nos6 (60.00%)
Toxicoderma (a disease of the skin caused by a toxic agent)2 (20.00%)

Most common interactions experienced by people in the use of Claforan, Netilmicin Sulfate, Doxicillin Sodium, Clavulanate Potassium:

InteractionNumber of reports
Maternal Drugs Affecting Foetus (chemical affecting the baby before birth taken by mother)10
Anaemia Neonatal8
Premature Baby8
Dermatitis Nos6
Caesarean Section6
Neonatal Respiratory Failure (a life-threatening condition in which respiratory function is inadequate to maintain the body's need for oxygen supply and carbon dioxide removal while at rest)6
Staphylococcal Infection Nos6
Neutropenia Neonatal (an abnormally low number of neutrophils in below a month baby)6
Haematuria (presence of blood in urine)4
Complications Of Maternal Exposure To Therapeutic Drugs4

Most common interactions experienced by people in long term use of Claforan, Netilmicin Sulfate, Doxicillin Sodium, Clavulanate Potassium:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.